Analysts think JAGX stock price could increase by 89%
May 09, 2025, 11:25 AM
-53.56%
What does JAGX do
Jaguar Health, a San Francisco-based pharmaceutical company with 49 employees, specializes in plant-derived medicines for gastrointestinal issues in humans and animals, including Mytesi for HIV patients and Canalevia-CA1 for dogs. The company went public on May 13, 2015, and operates through human and animal health segments.
3 analysts think JAGX stock price will increase by 89.00%. The current median analyst target is $16.32 compared to a current stock price of $8.63. The lowest analysts target is $16.16 and the highest analyst target is $16.80.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
